Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00915_DB01267_nanopub.RAozzvFi6FDYepcwcg2817rmy-zNG1KnlI_yOR8Mo2ZmQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00915_DB01267 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00915_DB01267 label "DDI between Amantadine and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, amantadine. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary. [drugbank_resource:DB00915_DB01267]" assertion.
- drugbank_resource:DB00915_DB01267 identifier "drugbank_resource:DB00915_DB01267" assertion.
- drugbank_resource:DB00915_DB01267 title "DDI between Amantadine and Paliperidone - The atypical antipsychotic agent, paliperidone, may decrease the therapeutic effect of the anti-Parkinson's agent, amantadine. This interaction may be due to the dopamine antagonist properties of paliperidone. Consider an alternate antipsychotic in those with Parkinson's disease or consider using clozapine or quetiapine if an atypical antipsychotic is necessary." assertion.
- drugbank:DB00915 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00915_DB01267 assertion.
- drugbank:DB01267 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00915_DB01267 assertion.